{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T10:15:35Z","timestamp":1768644935704,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by low platelet counts and increased bleeding risk. The disease may be induced by other disorders, including malignancies, autoimmune diseases, infectious agents or drugs. However, ITP has also been described following vaccinations, such as the measles\u2013mumps\u2013rubella vaccination. In rare cases, ITP may occur in children who received a DTaP-IP (diphtheria, tetanus, acellular pertussis vaccine and inactivated poliovirus) vaccine. Hereinafter, we report the first well-documented cases of ITP in an adult patient in the temporal context of a DTaP-IP vaccination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>This case report attempts to capture the life-threatening picture of a 36-year-old otherwise healthy Caucasian woman with newly diagnosed severe immune thrombocytopenia in the temporal context of a DTaP-IP vaccination. Four days after receiving the vaccine, the women presented to her primary care physician with malaise, fever and recurrent epistaxis. Clinical examination revealed oral petechiae, ecchymoses, and non-palpable petechiae on both legs. The patient was immediately referred to a local hematology unit where she developed hematuria and an intestinal bleeding (WHO Bleeding Grade III) requiring multiple transfusions. After receiving oral corticosteroids and intravenous immunoglobulins, her platelets gradually recovered. Common causes of secondary ITP were ruled out by laboratory investigations, bone marrow and peripheral blood examinations. This raises the possibility of a (secondary) vaccination-associated thrombocytopenia. To the best of our knowledge, this is the first well-documented case of a DTaP-IP vaccination-related ITP in an adult patient in the English literature.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Although a causal connection between both entities may not be established, we would like to raise awareness in clinicians that ITP following DTaP-IP vaccinations is potentially not limited to children, but may also occur in adults. Users of DTaP-IP booster vaccines should be alert of the possibility of such adverse reactions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-022-00686-z","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T09:04:48Z","timestamp":1651568688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Severe immune thrombocytopenia following diphtheria, tetanus, pertussis and polio vaccination in a 36-year-old Caucasian woman: a case report"],"prefix":"10.1186","volume":"27","author":[{"given":"Onno","family":"K\u00fcster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Schmohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3277-0301","authenticated-orcid":false,"given":"Maximilian Andreas","family":"Storz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"issue":"Suppl 5","key":"686_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000492187","volume":"41","author":"A Matzdorff","year":"2018","unstructured":"Matzdorff A, Meyer O, Ostermann H, Kiefel V, Eberl W, K\u00fchne T, et al. Immune thrombocytopenia\u2013current diagnostics and therapy: recommendations of a joint working group of DGHO, \u00d6GHO, SGH, GPOH, and DGTI. Oncol Res Treat. 2018;41(Suppl 5):1\u201330.","journal-title":"Oncol Res Treat"},{"issue":"1 Suppl 2","key":"686_CR2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1053\/j.seminhematol.2008.12.005","volume":"46","author":"DB Cines","year":"2009","unstructured":"Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46(1 Suppl 2):S2-14.","journal-title":"Semin Hematol"},{"issue":"11","key":"686_CR3","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386\u201393.","journal-title":"Blood"},{"key":"686_CR4","first-page":"1","volume":"23","author":"GM Podda","year":"2020","unstructured":"Podda GM, Fiorelli EM, Birocchi S, Rambaldi B, Di Chio MC, Casazza G, et al. Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review. Platelets. 2020;23:1\u20137.","journal-title":"Platelets"},{"issue":"7\u20138","key":"686_CR5","first-page":"337","volume":"131","author":"M Colovi\u0107","year":"2003","unstructured":"Colovi\u0107 M, Jurisi\u0107 V, Colovi\u0107 N, Milji\u0107 P. Thrombotic thrombocytopenic purpura: clinic\u2013pathologic characteristics and therapy. Srp Arh Celok Lek. 2003;131(7\u20138):337\u201344.","journal-title":"Srp Arh Celok Lek"},{"issue":"6","key":"686_CR6","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.hoc.2009.08.009","volume":"23","author":"R Stasi","year":"2009","unstructured":"Stasi R, Willis F, Shannon MS, Gordon-Smith EC. Infectious causes of chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009;23(6):1275\u201397.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"686_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/jcp.2005.027797","volume":"59","author":"M Colovic","year":"2006","unstructured":"Colovic M, Jurisic V, Jankovic G, Jovanovic D, Nikolic LJ, Dimitrijevic J. Interferon alpha sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia: case report and review of literature. J Clin Pathol. 2006;59(8):879\u201381.","journal-title":"J Clin Pathol"},{"issue":"2\u20133","key":"686_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12026-014-8597-x","volume":"60","author":"C Perricone","year":"2014","unstructured":"Perricone C, Ceccarelli F, Nesher G, Borella E, Odeh Q, Conti F, et al. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol Res. 2014;60(2\u20133):226\u201335.","journal-title":"Immunol Res"},{"key":"686_CR9","volume-title":"Manual h\u00e4matologie","author":"R Fuchs","year":"2022","unstructured":"Fuchs R. Manual h\u00e4matologie. 32nd ed. Berlin: Stolberg: Nora Verlag; 2022.","edition":"32"},{"issue":"22","key":"686_CR10","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780\u2013817.","journal-title":"Blood Adv"},{"key":"686_CR11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0124","author":"U Hamiel","year":"2016","unstructured":"Hamiel U, Kventsel I, Youngster I. Recurrent immune thrombocytopenia after influenza vaccination: a case report. Pediatrics. 2016. https:\/\/doi.org\/10.1542\/peds.2016-0124.","journal-title":"Pediatrics"},{"issue":"13","key":"686_CR12","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2169\/internalmedicine.3991-19","volume":"59","author":"Y Yamamoto","year":"2020","unstructured":"Yamamoto Y, Ohara Y, Iwai A, Hara R, Matsuki T, Fukushima K, et al. Influenza vaccination\u2014associated acute thrombocytopenia and diffuse alveolar hemorrhage. Intern Med. 2020;59(13):1633\u20137.","journal-title":"Intern Med"},{"key":"686_CR13","first-page":"7913092","volume":"2016","author":"J Nagasaki","year":"2016","unstructured":"Nagasaki J, Manabe M, Ido K, Ichihara H, Aoyama Y, Ohta T, et al. Postinfluenza vaccination idiopathic thrombocytopenic purpura in three elderly patients. Case Rep Hematol. 2016;2016:7913092.","journal-title":"Case Rep Hematol"},{"issue":"5","key":"686_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ajh.26132","volume":"96","author":"E-J Lee","year":"2021","unstructured":"Lee E-J, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, et al. Thrombocytopenia following pfizer and moderna SARS-CoV-2 vaccination. Am J Hematol. 2021;96(5):534\u20137.","journal-title":"Am J Hematol"},{"key":"686_CR15","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S30704","author":"JM Helms","year":"2021","unstructured":"Helms JM, Ansteatt KT, Roberts JC, Kamatam S, Foong KS, Labayog J-MS, et al. Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. J Blood Med. 2021. https:\/\/doi.org\/10.2147\/JBM.S30704.","journal-title":"J Blood Med"},{"issue":"11","key":"686_CR16","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1007\/s42399-020-00521-8","volume":"2","author":"S Bhattacharjee","year":"2020","unstructured":"Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Compr Clin Med. 2020;2(11):2048\u201358.","journal-title":"SN Compr Clin Med"},{"issue":"4","key":"686_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3109\/08880019309029521","volume":"10","author":"LS Arya","year":"1993","unstructured":"Arya LS, Ghai OP, Saraya AK. Thrombocytopenic purpura following DPT vaccination. Pediatr Hematol Oncol. 1993;10(4):381\u20133.","journal-title":"Pediatr Hematol Oncol"},{"issue":"10","key":"686_CR18","first-page":"934","volume":"53","author":"A Bhowmik","year":"2016","unstructured":"Bhowmik A, Biswas T. Immune thrombocytopenia following diphtheria pertussis\u2013tetanus and oral polio vaccine. Indian Pediatr. 2016;53(10):934\u20135.","journal-title":"Indian Pediatr"},{"issue":"12","key":"686_CR19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S1726-4901(10)70138-6","volume":"73","author":"Y-L Hsieh","year":"2010","unstructured":"Hsieh Y-L, Lin L-H. Thrombocytopenic purpura following vaccination in early childhood: experience of a medical center in the past 2 decades. J Chin Med Assoc. 2010;73(12):634\u20137.","journal-title":"J Chin Med Assoc"},{"key":"686_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000048961.08486.d1","author":"T Jadavji","year":"2003","unstructured":"Jadavji T, Scheifele D, Halperin S, Canadian paediatric society\/health cananda immunization monitoring program. Thrombocytopenia after immunization of Canadian children. Pediatr Infect Dis J. 2003. https:\/\/doi.org\/10.1097\/01.inf.0000048961.08486.d1.","journal-title":"Pediatr Infect Dis J"},{"issue":"21","key":"686_CR21","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","volume":"129","author":"MP Lambert","year":"2017","unstructured":"Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood. 2017;129(21):2829\u201335.","journal-title":"Blood"},{"issue":"10","key":"686_CR22","first-page":"e5849","volume":"11","author":"M Samson","year":"2019","unstructured":"Samson M, Fraser W, Lebowitz D. Treatments for primary immune thrombocytopenia: a review. Cureus. 2019;11(10):e5849.","journal-title":"Cureus"},{"issue":"99","key":"686_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijid.2020.07.085","volume":"1","author":"P David","year":"2020","unstructured":"David P, Shoenfeld Y. ITP following vaccination. Int J Infect Dis. 2020;1(99):243\u20134.","journal-title":"Int J Infect Dis"},{"key":"686_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.phrs.2015.08.003","volume":"100","author":"LE Guimar\u00e3es","year":"2015","unstructured":"Guimar\u00e3es LE, Baker B, Perricone C, Shoenfeld Y. Vaccines, adjuvants and autoimmunity. Pharmacol Res. 2015;100:190\u2013209.","journal-title":"Pharmacol Res"},{"issue":"8","key":"686_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.it.2009.05.005","volume":"30","author":"S Kivity","year":"2009","unstructured":"Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity\u2013friends or foes? Trends Immunol. 2009;30(8):409\u201314.","journal-title":"Trends Immunol"},{"issue":"5","key":"686_CR26","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.4161\/hv.23601","volume":"9","author":"V Cecinati","year":"2013","unstructured":"Cecinati V, Principi N, Brescia L, Giordano P, Esposito S. Vaccine administration and the development of immune thrombocytopenic purpura in children. Hum Vaccin Immunother. 2013;9(5):1158\u201362.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"686_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12185-020-02866-1","volume":"112","author":"H Yokomichi","year":"2020","unstructured":"Yokomichi H, Tanaka-Taya K, Koshida R, Nakano T, Yasui Y, Mori M, et al. Immune thrombocytopenic purpura risk by live, inactivated and simultaneous vaccinations among Japanese adults, children and infants: a matched case-control study. Int J Hematol. 2020;112(1):105\u201314.","journal-title":"Int J Hematol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00686-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-022-00686-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00686-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T21:11:43Z","timestamp":1651612303000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-022-00686-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["686"],"URL":"https:\/\/doi.org\/10.1186\/s40001-022-00686-z","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"assertion":[{"value":"2 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave oral and written consent to the authors to publish her de-identified case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}